Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 11 | -$6.60 | -$2.74 | -$4.45 |
| Q2 2026 | 12 | -$2.41 | -$1.35 | -$2.06 |
| Q3 2026 | 12 | -$1.79 | -$0.55 | -$1.11 |
| Q4 2026 | 10 | -$2.44 | -$1.51 | -$1.92 |
| Q1 2027 | 5 | -$2.30 | -$1.43 | -$1.82 |
| Q2 2027 | 5 | -$2.71 | -$1.68 | -$2.14 |
| Q3 2027 | 5 | -$0.41 | -$0.26 | -$0.33 |
| Q4 2027 | 5 | -$1.21 | -$0.75 | -$0.95 |
Moderna Inc last posted its earnings results on Friday, May 1st, 2026. The company reported $-3.4 earnings per share for the quarter, topping analysts' consensus estimates of $-4.45 by $1.05. The company had revenue of 389.00 M for the quarter and had revenue of 1.94 B for the year. Moderna Inc has generated $-7 earnings per share over the last year ($-7.26 diluted earnings per share) and currently has a price-to-earnings ratio of -7.28. Moderna Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/01/2026 | Q1 2026 | -$4.45 | -$3.40 | 1.05 | $236.36 M | $389.00 M |
| 02/20/2026 | Q4 2025 | N/A | -$2.11 | N/A | $635.15 M | $678.00 M |
| 11/06/2025 | Q3 2025 | -$1.87 | -$0.51 | 1.36 | $920.86 M | $1.02 B |
| 08/01/2025 | Q2 2025 | -$2.99 | -$2.13 | 0.86 | $110.80 M | $142.00 M |
| 05/01/2025 | Q1 2025 | -$2.92 | -$2.52 | 0.4 | $106.18 M | $107.00 M |
| 02/21/2025 | Q4 2024 | N/A | -$2.91 | N/A | $942.82 M | $956.00 M |
| 11/07/2024 | Q3 2024 | -$1.91 | $0.03 | 1.94 | $1.25 B | $1.86 B |
| 08/01/2024 | Q2 2024 | -$3.35 | -$3.33 | 0.02 | $128.41 M | $221.00 M |
| 05/02/2024 | Q1 2024 | -$3.56 | -$3.08 | 0.48 | $93.26 M | $167.00 M |
| 02/23/2024 | Q4 2023 | N/A | $0.57 | N/A | N/A | $2.81 B |
| 11/03/2023 | Q3 2023 | N/A | -$9.53 | N/A | N/A | $1.83 B |
| 08/03/2023 | Q2 2023 | -$3.84 | -$3.62 | 0.22 | N/A | $344.00 M |
| 05/04/2023 | Q1 2023 | -$1.77 | $0.20 | 1.97 | N/A | $1.84 B |
| 02/24/2023 | Q4 2022 | N/A | $3.81 | N/A | N/A | $5.15 B |
| 11/03/2022 | Q3 2022 | $3.29 | $2.67 | -0.62 | N/A | $3.22 B |
| 08/03/2022 | Q2 2022 | $4.55 | $5.55 | 1 | N/A | $4.57 B |
| 05/04/2022 | Q1 2022 | $5.21 | $9.09 | 3.88 | N/A | $5.94 B |
| 02/25/2022 | Q4 2021 | N/A | $12.03 | N/A | N/A | $6.95 B |
| 11/04/2021 | Q3 2021 | $9.05 | $8.27 | -0.78 | N/A | $4.83 B |
| 08/05/2021 | Q2 2021 | $5.96 | $6.93 | 0.97 | N/A | $4.22 B |
In the previous quarter, Moderna Inc (:MRNA) reported $-3.4 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.45 by $1.05.
The conference call for Moderna Inc's latest earnings report can be listened to online.
The conference call transcript for Moderna Inc's latest earnings report can be read online.
Moderna Inc (:MRNA) has a recorded annual revenue of $1.94 B.
Moderna Inc (:MRNA) has a recorded net income of $-2,822,000,000.Moderna Inc has generated $-7.26 earnings per share over the last four quarters.
Moderna Inc (:MRNA) has a price-to-earnings ratio of -7.28 and price/earnings-to-growth ratio is -3.63.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED